Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia
By Xiaoling Wang, V. Sutton, J. O. Peraza-Llanes, Zhiyin Yu, R. Rosetta, Y. Kou, Tanya N Eble, Ankita Patel, Christina Thaller, P. Fang and 1 more. 2007
279 citations recorded by the source corpus.
Subfields: Cell Biology, Molecular Biology
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cell Biology
In Molecular Biology
Citations in the corpus
- Wnt/β-catenin signaling and disease. (2012, unknown): “This disease is characterized by skin abnormalities and other developmental defects (Grzeschik et al., 2007; Wang et al., 2007).”
- Structural basis of WLS/Evi-mediated Wnt transport and secretion (2020, background): “Loss of function mutations in PORCN, an X-linked gene, are lethal in males (Grzeschik et al., 2007; Wang et al., 2007), while drugs that inhibit PORCN are effective treatment for Wnt-addicted cancers in preclinical models and are currently in ongoing clinical trials (Zhong and Virshup, 2020).”
- Precise Regulation of Porcupine Activity Is Required for Physiological Wnt Signaling (2012, background): “Analysis of PORCNMutations Associated with FDH—Inherited and postzygotic mutations in the PORCN gene cause the disorder focal dermal hypoplasia (33, 34).”
- Targeting Protein Lipidation in Disease (2012, background): “Mutations in the Porcn gene in humans cause Goltz syndrome or focal dermal hypoplasia, an X-linked dominant disorder characterized by multiple skin malformations [55].”
- An in vitro fatty acylation assay reveals a mechanism for Wnt recognition by the acyltransferase Porcupine (2017, background): “Mutations in the PORCN gene cause focal dermal hypoplasia, an X-linked disorder characterized by multiple congenital abnormalities (16).”